David Miller compensation by year
CHAMPIONS ONCOLOGY Summary Compensation Table · all 10 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Salary | $215,000 | $230,000 | $250,000 | $250,000 | $250,000 | $260,000 | $260,000 | $260,000 | $278,333 | $315,000 |
| Bonus | $15,000 | $26,000 | $0 | $40,000 | $35,000 | $35,000 | $25,000 | $0 | $30,000 | $25,000 |
| Stock awards | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Option awards | $18,369 | $32,669 | $0 | $82,915 | $26,681 | $26,538 | $9,303 | $0 | $7,444 | $48,464 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total | $248,369 | $288,669 | $250,000 | $372,915 | $311,681 | $321,538 | $294,303 | $260,000 | $315,777 | $388,464 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CHAMPIONS ONCOLOGY, INC. DEF 14A filed August 28, 2026, accession 0001628280-26-059373, and prior-year filings. Open the filing on EDGAR.
How this page was built: the CHAMPIONS ONCOLOGY, INC. filed document, accession 0001628280-26-059373. Every figure is read from that document and cited to the page and table it appears in. Filed August 28, 2026.
Equity holdings
unvested awards at FY2026 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 15,000 | — | $5.72 |
Per the Outstanding Equity Awards at Fiscal Year-End table in CHAMPIONS ONCOLOGY, INC.'s FY2026 proxy; value at the fiscal year-end close, as the company printed it.
CHAMPIONS ONCOLOGY’s named executive officers, FY2026
as the company reported each| Named executive officer | Role | FY2026 total |
|---|---|---|
| Robert Brainin | Chief Executive Officer | $3,567,022 |
| David Miller · this page | Chief Financial Officer | $388,464 |
| Ronnie Morris | Chief Executive Officer | $233,333 |
Board service
CHAMPIONS ONCOLOGY board · FY2023How this board is paid
Company policy: CHAMPIONS ONCOLOGY pays directors a $35,000 cash retainer. As stated in CHAMPIONS ONCOLOGY's FY2023 proxy.
David Miller's compensation dossier, CHAMPIONS ONCOLOGY
You have read David Miller's totals and holdings. The dossier adds each equity grant CHAMPIONS ONCOLOGY disclosed for David Miller and CHAMPIONS ONCOLOGY's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full CHAMPIONS ONCOLOGY compensation record
free company briefThis page is one person within CHAMPIONS ONCOLOGY's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CHAMPIONS ONCOLOGY's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CHAMPIONS ONCOLOGY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order CSBR
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.